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Abstract
Objective: To determine HIV-1 RNA load during the third trimester of pregnancy and evaluate its effect on in utero
and intra-partum/postpartum transmissions in a breastfeeding population.
Design: A nested case-control study within a PMTCT cohort of antiretroviral therapy naive pregnant women and
their infants.
Methods: A case was a mother who transmitted HIV-1 to her infant (transmitter) who was matched to one HIV-1
positive but non-transmitting mother (control).
Results: From a cohort of 691 pregnant women, 177 (25.6%) were HIV-1 positive at enrolment and from these 29
(23%) transmitted HIV-1 to their infants, 10 and 19 during in utero and intra-partum/postpartum respectively.
Twenty-four mothers sero-converted after delivery and three transmitted HIV-1 to their infants. Each unit increase
in log10 viral load was associated with a 178 cells/mm
3 and 0.2 g/dL decrease in TLC and hemoglobin levels, p =
0.048 and 0.021 respectively, and a 29% increase in the risk of transmission, p = 0.023. Intra-partum/postpartum
transmitters had significantly higher mean viral load relative to their matched controls, p = 0.034.
Conclusion: Antenatal serum HIV-1 RNA load, TLC and hemoglobin levels were significantly associated with
vertical transmission but this association was independent of transmission time. This finding supports the rationale
for preventive strategies designed to reduce vertical transmission by lowering maternal viral load.
Introduction
Sub-Saharan Africa continues to be the epicentre of the
HIV-1 epidemic contributing more than 90% of the 370
000 infants who acquire the infection from their
mothers annually worldwide [1]. More than half of the
HIV-1 infected children die before their second birthday
[2]. The HIV-1 epidemic among pregnant women poses
a challenge to child health and survival of future
generations.
Zimbabwe is among the Sub-Saharan countries with
the highest HIV-1 prevalence in the world. Among 600
0 0 0w o m e nw h og e tp r e g n a n ta n n u a l l y ,H I V - 1p r e v a -
lence peaked to 30% in 1997 [3] but has steadily
declined over the years to 15.6% in 2006 [1,4]. Without
any intervention, 30-49% of the children born to HIV-1
positive mothers are infected by the virus [5]. In Zim-
babwe the estimate of mother to child transmission rate
of HIV-1 has been shown to be 30% [6]. The reason
why some mothers transmit to their infants whilst the
majority does not is not well documented.
Maternal HIV-1 RNA load has been shown to be the
strongest predictor of vertical transmission [7,8]. In
Zimbabwe, among exclusively breastfed infants, in utero
and intra-partum transmission has been shown to be
9.4% and 16%, respectively [6] with a postpartum trans-
mission rate of 12% [9]. However, both studies have
made no reference to maternal viral load. More so,
other previous studies have pooled the three transmis-
sion periods; in utero, intra-partum and postpartum
cases and this may underestimate time specific risk fac-
tors of vertical transmission [8].
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populace which translates to high vertical transmission
rates, the desire to have future pregnancies among HIV-
1 positive mothers has increased from 3% to more than
55% more so with the advent of HIV-1 Prevention of
Mother To Child Transmission (PMTCT) initiatives
[10,11]. Therefore there is a need for the development
of a simple, effective and time specific vertical transmis-
sion preventive strategy to curb this epidemic. This
study aims to determine HIV-1 RNA load during the
third trimester of pregnancy and evaluate its association
with in utero and intra-partum/postpartum vertical
transmissions.
Methodology
Study Design and Setting
This was a nested case-control study in which the cases
and controls were sampled from an antiretroviral ther-
apy naive PMTCT cohort of pregnant women attending
Antenatal Clinics at Epworth, Seke North and Saint
Mary’s Chitungwiza, all around Harare. Antiretroviral
drugs were not readily available in Zimbabwe at the
time of recruitment of study participants.
Study Population and Procedures
The study population consisted of two groups of HIV-1
positive pregnant women. The main group comprised of
pregnant women who were HIV-1 positive at enrolment,
referred to as having chronic HIV-1 infections and a
minor group of women who were HIV-1 negative dur-
ing pregnancy but later on sero-converted after delivery
during the follow-up period, regarded as having acute
HIV-1 infections. Each HIV-1 positive mother who
transmitted the virus to her infant (case) was matched
to one HIV-1 positive but non-transmitting mother
(control). Matching of cases and controls was done with
respect to maternal age, educational level, marital and
socio-economic status, parity, alcohol intake, sexually
transmitted infections, the date of last menstruation,
and uptake of single dose nevirapine therapy.
Pregnant women were enrolled at 36 gestational weeks
in a national PMTCT program between April and Sep-
tember 2002. Pre-and post-HIV test counseling was pro-
vided. Single dose nevirapine therapy was offered to
HIV-1 positive mothers during labour and to their
infants within 72 hours post delivery. Mothers were
encouraged to exclusively breastfeed during the first six
months. Follow-up was from delivery, six weeks, four
and nine months and thereafter three monthly until two
years. Follow up visits generally coincided with infant
immunization visits. At each subsequent follow-up visit,
HIV-1 negative mother and infants were re-tested for
HIV-1 antibodies and HIV-1 DNA, respectively. Serum
samples from the HIV-1 negative mothers and their
infants were aliquoted and appropriately stored for
further tests in the event that they sero-converted.
Mothers and Infants Demographic characteristics and
Examination
All mothers answered a structured questionnaire at
enrolment and information regarding their socio-
demographics, sexual behavior, obstetric and reproduc-
tive health issues was obtained. A gynecologist
performed physical and gynecological examinations.
A pediatrician examined infants. Date of birth, birth
weight, gender, single dose nevirapine therapy and
breastfeeding patterns were recorded. Infant deaths were
also recorded during the follow up period.
Mothers’ Tests
Serial HIV-1/2 algorithm antibody tests were done using
Determine (Abbott Diagnostics, Illinois USA) and Ora-
Quick (Abbott Diagnostics, Illinois, USA) rapid kits on
mothers’ serum samples. EDTA-anti-coagulated venous
blood samples were processed within six hours for full
blood counts using Abbott Diagnostic Cell Dyne 3500R
SL Hematology Analyser. Total Lymphocyte Count
(TLC) was enumerated as the total white blood cell
count multiplied by the lymphocyte percentage. In this
resource poor setting, TLC was used as a surrogate mar-
ker for CD4 cell count since by then, the capacity to
determine the latter was not readily available to the gen-
eral public due to prohibitive costs. TLC of 1200 cells/
mm
3 was the threshold value used equivalent to a CD4
count of 200 cells/mm
3 [12,13].
Blood samples were shipped on dry ice to the Institute
of Microbiology at the University of Oslo in Norway for
further laboratory analysis. Maternal baseline serum
samples were quantified for HIV-1 RNA load using an
automated TaqMan Roche Amplicor 1.5 Monitor Test
(Cobas AmpliPrep/Cobas TaqMan, Roche Diagnostics,
Branchburg NJ) according to the manufacturer’s instruc-
tions. As for sero-converters, the first HIV-1 positive
sample was quantified. The linear range of the test was
between 40 (1.6log10)a n d1 0
7 (7log10)c o p i e s / m La n d
the detection limit of the assay is 40 copies/mL based
on a sample volume of 1 mL thus the detection limit for
this study was 400 copies/mL based on a serum sample
volume of 100 μLt h a tw a st o p p e du pt o1m Lw i t h
HIV-1 negative serum.
Infants’ Tests
Infants’ venous EDTA whole blood samples were col-
lected at each follow up visit. Samples were stored at
-86°C until testing. Detection of infants’ HIV-1 infection
was determined using a qualitative 1.5 Roche Amplicor
HIV-1 DNA PCR kit (Roche Diagnostics Incorporation,
Branchburg, New Jersey). Testing was done in the
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University of Zimbabwe. Infants that tested HIV-1 DNA
PCR positive on whole blood collected within 10 days of
birth were considered to be infected in utero.I n f a n t s
who had negative HIV-1 DNA PCR results within the
first 10 days of life and positive results at six weeks
postpartum and/or thereafter were considered to be
infected intra-partum/postpartum [14].
Statistical Analysis
Data were collected and analyzed using STATA version
10 from Texas and SPSS version 16.0 from Illinois,
USA. Viral load values were log10 transformed. Viral
load values of below the detection limit were assigned
half the value of the detection limit. The Student t-test
was used to compare mean log10 viral load between
transmitting and non transmitting mothers, chronic and
acute HIV-1 infections, in utero and intra-partum/post-
partum transmitters. Mean log10 viral load of each of
these groups was also compared with their respective
matched controls. Regression analysis was used to inves-
tigate the association between log10 viral load, TLC or
hemoglobin levels, and vertical transmission. Tests of
statistical significance included the 95% confidence
interval of relative risks, two sided p values based on
Chi-squared and Fisher’s exact tests.
Ethical Consideration
The study was approved by the Medical Research Coun-
cil of Zimbabwe and the Ethical Review Committee in
Norway. Written consent to participate in the research
study was obtained from the mothers and they were free
t od i s c o n t i n u ea ta n yg i v e nt i m ew i t h o u ta n yp r e j u d i c e .
Mothers also consented to have their blood samples and
that of their index infants’ used for future HIV related
research.
Results
Demographic and reproductive health characteristics of
32 transmitters and matched 32 non-transmitters
There was no statistical significant difference with
respect to socio-demographic characteristics, sexual
behavior, reproductive genital tract infections and medi-
cal history between the 64 HIV-1 positive mothers con-
stituting this study population and the rest (113) of the
HIV-1 positive mothers in the cohort. However, the 32
transmitters and matched 32 non-transmitters were
more likely to have more children relative to the other
113 HIV-1 positive but non transmitting mothers who
were not part of the study population, p = 0.016.
Mothers’ mean age (SD) was 26.0 (5.6) years with that
of transmitters and non-transmitters being 26.3 (5.6)
and 25.6 (5.6) years respectively p = 0.610. All the
mothers had spontaneous vaginal deliveries. There were
no statistically significant differences between transmit-
ting and non-transmitting mothers with respect to age,
level of education, parity, type of marriage, socio-
economic status and number of life sexual partners. The
transmitters and non-transmitters also had comparable
burdens of reproductive tract infections and obstetric
history, see table 1.
When the transmitters were stratified by time of
infecting their infants, there were no statistically signifi-
cant differences with respect to demographics, sexual
behaviour, reproductive health characteristics and medi-
cal history between those who transmitted during in
utero and those who transmitted intra-partum/
postpartum.
Mothers with acute HIV-1 infection, the sero-
converters, were generally younger relative to HIV-1
negative mothers in the cohort, with mean age of 21.8
(4.6) and 23.7(5) years respectively although not sta-
tistically significant, p = 0.06. There were also no sta-
tistical significant differences with respect to parity,
level of education, age of sexual debut and reproduc-
tive tract infections between these two groups. Sero-
converters were more likely to be single, have more
than one sexual partner(s), syphilis, clinical warts, and
a history of blood transfusion with p values of 0.000,
0.019, 0.041, 0.002 and 0.033 respectively. Transmit-
ting sero-converters were more likely to report having
a travelling partner, p = 0.022 and were significantly
younger than transmitters with chronic HIV-1 infec-
tions, with mean age of 20(1.7) and 27(5.5) years
respectively, p = 0.04.
HIV-1 Prevalence and Transmission
At enrolment, 691 pregnant women attending national
PMTCT program were sampled between April and Sep-
tember 2002. Of these, 177 (25.6%) and 514 (74.4%)
were HIV-1 positive and negative respectively. There
were two stillbirths each among the HIV-1 positive and
negative mothers and these were excluded from analysis.
From the 176 mothers with chronic HIV-1 infections
that delivered live births 134 (76%) mother-baby pairs
were successfully followed up and tested, see figure 1.
There were no statistically significant differences with
respect to socio-demography and reproductive health
characteristics between the 42 women lost to follow up
and the 134 with complete data sets. Twenty-nine (22%)
mothers transmitted the virus to their infants, 10 (34%)
and 19 (66%) during in utero and intra-partum/postpar-
tum transmissions with rates of 7.5% and 15.3%
respectively.
Out of the 514 HIV-1 negative mothers at baseline, 24
sero-converted during the 2 year follow-up period, giv-
ing an HIV-1 cumulative incidence rate of 2.3 per hun-
dred women years. Among the 24 sero-converters with
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virus to their infants through breastfeeding around 9
months postpartum. All the three infants were exposed,
through breast milk for about three months before
acquiring HIV-1 infection at about 12 months
postpartum.
Thus there were a total of 32 transmitting mothers in
this cohort, giving an overall transmission rate of 21.3%.
Maternal Viral Load and Transmission
Of the 32 transmitters and 32 matched non-transmitters,
26 (81%) and 20 (63%), respectively had detectable serum
H I V - 1R N Al o a dr a n g i n gf r o m4 0 0t o30 0 00 0 0c o p i e s /
mL. Vertical transmission occurred throughout the entire
range with 90% of the transmissions occurring below 16
000 HIV-1 RNA copies/mL. The mean (95% Confidence
Interval) log10 viral load was 3.55(3.15-3.96) and 2.92
Table 1 Socio-demographics, sexual behavior, medical history and baby characteristics of the 32 transmitters and 32
non-transmitters
Variable Transmitter
N = 32 (%)
Non Transmitters
N = 32 (%)
RR (95% CI)
Age in years
Mean (sd) 26.3 (5.6) 25.6 (5.6) 1.01 (0.95-1.08)
Years in school
< 8 4/32 (13) 3/32 (9) 1.16 (0.58-2.33)
Parity
At least 1 child 28/32 (88) 25/32 (78) 1.40 (0.60-3.30)
Polygamous marriage
Yes 4/31 (13) 4/30 (13) 0.98 (0.47-2.06)
Subsidised income
Yes 4/32 (13) 8/32 (25) 0.62 (0.27-1.43)
Age at sexual debut
≤ 16 years 6/32 (19) 3/32 (9) 1.41 (0.82-2.42)
Life time partners
> 1 17/32 (53) 16/32 (50) 1.06 (0.65-1.74)
Vaginal discharge
Abnormal 15/32 (47) 13/31 (42) 1.10 (0.68-1.79)
Genital ulcer
Present 5/32 (16) 3/30 (10) 1.25 (0.69-2.28)
Dysuria
Yes 7/32 (22) 4/31 (13) 1.32 (0.78-2.25)
Lymphadenopathy
Yes 3/28 (11) 1/31 (3) 1.65 (0.87-3.12)
Abortion history
Yes 7/32 (22) 3/32 (9) 1.51 (0.92-2.49)
Infant death history
Yes 4/32 (13) 7/32 (22) 0.69 (0.30-1.57)
Schistosomiasis infection history
Yes 7/32 (22) 4/31 (13) 1.32 (0.78-2.24)
Mothers’ARV Prophylaxis
No 17/32 (53) 16/32 (50) 1.00 (0.60-1.66)
Infant gender
Male 14/30 (47) 12/29 (41) 1.11 (0.67-1.83)
Birth weight
<2500 2/31 (6) 1/30 (3) 1.36 (0.58-3.15)
Deceased infant
Yes 9/31 (29) 2/30 (7) 4.35 (1.02-18.52)*
Breastfed
Yes 28/31 (90) 19/25 (76) 1.79 (0.69-4.64)
Baby ARV prophylaxis
Yes 16/27 (59) 13/25 (52) 0.87 (0.51-1.49)
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tively, p = 0.018, see table 2. For each unit increase in
log10 viral load, the risk of transmission increased by
29%, p = 0.023. Mean log10 (SD) viral load of mothers
with acute and chronic HIV-1 infection was 4.22 (1.01)
and 3.55 (1.09) respectively, p = 0.317. Mean log10 (SD)
viral load of transmitting sero-converters and non-trans-
mitting sero-converters were 3.99 (1.34) and 2.77 (0.81)
respectively, p = 0.248. There was no statistical signifi-
cant difference in mean log10 viral load between in utero
Figure 1 Summary of the sampling of the 32 transmitters and 32 non-transmitters.
Table 2 Baseline HIV-1 RNA load, TLC and hemoglobin levels of 32 transmitters and non-transmitters
Variable Transmitters
N=3 2
Non-transmitters
N=3 2
RR (95% CI)
Hemoglobin g/dl
<10 7/32 (22) 2/32 (6) 1.71 (1.08-2.69)*
TLC
Mean cells/mm
3(sd) 2147 (111) 2505 (132) 0.99 (0.99-0.99)*
Viral load
Mean log10 copies/ml 3.55 (1.12) 2.92 (0.92) 1.29 (1.07-1.55)*
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transmitters generally had higher mean log10 viral load
compared to their matched controls though not statisti-
cally significant and similarly intra-partum/postpartum
transmitters had significantly higher mean viral load rela-
tive to their respective matched controls, p = 0.034.
Among the 32 transmitting and 32 non-transmitting
mothers 6 (19%) and 12 (37.5%), respectively had unde-
tectable viral load respectively and none of them were
from the acute infection subgroup. Mothers with unde-
tectable viral load were less likely to transmit when
compared to mothers with detectable viral load. There
were no statistically significant differences regarding
socio-demographic and reproductive health characteris-
tics between mothers with detectable and undetectable
viral loads.
HIV-1 RNA load, TLC, Hemoglobin levels and Transmission
Mean TLC for transmitting mothers and non-transmit-
ting mothers were 2147 cells/mm
3 and 2505 cells/mm
3
respectively, p = 0.04. HIV-1 RNA load negatively corre-
lated with TLC, correlation coefficient of -0.254. Each
unit increase in log10 viral load was associated with a
178 cells/mm
3 decrease in TLC, (p = 0.048). There were
no statistical significant differences in mean TLC of
mothers with acute and chronic HIV-1 infections and
also between in utero transmitters and their respective
controls. However, there was a statistically significant
difference in mean TLC between intra-partum/postpar-
tum transmitters and their matched controls, p = 0.030,
see table 3.
Each unit increase in log10 viral load was associated
with a 0.2 g/dL decrease in hemoglobin levels, p =
0.021. There were no statistically significant differences
in hemoglobin levels between mothers with acute and
chronic HIV-1 infection and also among in utero and
intra-partum/postpartum transmitters, p = 0.870 and
0.980 respectively. Mean hemoglobin levels were signifi-
cantly different between intra-partum/postpartum
transmitters relative to their matched controls p =
0.038, see table 3. Anaemic mothers with hemoglobin
levels of less than 10 g/dL were 1.7 times more likely to
transmit compared to those with hemoglobin levels of
more than 10 g/dL in univariate analysis. After control-
ling for the effect of viral load and TLC this relationship
ceased to be significant.
Infant Factors, Mortality and Transmission
Infant sex, birth weight, single dose nevirapine therapy
and breastfeeding patterns were not significantly differ-
ent neither between transmitters and non-transmitters
nor among in utero and intra-partum/postpartum trans-
mitters. HIV-1 infected infants were 4 times more likely
to die compared to those uninfected (p = 0.003), see
table 1. The odds of dying were 14 (p = 0.04) for infants
infected in utero compared to their respective unin-
fected controls.
Discussion
This is a first study in Zimbabwe where viral load was
determined in pregnant women and was related to time
point vertical transmission. This nested case-control
study of Harare peri-urban pregnant women provided
data on risk factors of vertical transmission by assessing
maternal HIV-1 RNA load, TLC and hemoglobin levels
of transmitting and non-transmitting mothers, who were
otherwise similar with respect to demographic and
reproductive health characteristics.
Of note was the highly significant relationship
between antenatal HIV-1 RNA load, at 36 weeks gesta-
tional period, with vertical transmission. Similar to other
studies [7,8,15,16], transmitting mothers had a signifi-
cantly higher viral load compared to non-transmitting
mothers.
No threshold for transmission was observed in this
cohort that could predict transmission or non-
transmission, as transmission occurred throughout the
whole range of viral load values, contrary to previous
Table 3 Comparison of in utero and intra-partum/postpartum transmitters and their respective matched non-
transmitting controls with respect to viral load, TLC and hemoglobin levels
Variable In utero
transmitters
N=1 0
In utero matched
controls
N=1 0
RR (95%CI) Intra/Postpartum
Transmitters
N=2 2
Intra-/postpartum
Matched Controls
N=2 2
RR (95% CI)
Hemoglobin
Mean g/dl (sd) 10.7 (0.9) 10.5 (1.3) 1.10 (0.74-1.65) 10.5 (1.5) 11.4 (1.0) 0.82 (0.71-0.94)*
TLC
Mean cells/ml
(SD)
2133 (724) 2207 (443) 0.99 (0.98-1.00) 2153 (576) 2632 (790) 0.98 (0.97 = 0.99)*
Viral load
Mean log10
copies/ml
3.5 (1.2) 3.0 (0.9) 1.60 (0.70-3.79) 3.6 (1.1) 2.9 (1.0) 2.0 (1.02-3.81)*
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was associated with in utero and intra-partum/postpar-
tum transmissions contrary to some studies [18-20].
Our findings are analogous to those by Garcia et al.,
where serum HIV-1 RNA levels predicted the risk but
not the timing of vertical transmission [21]. While viral
load was an important determinant of vertical transmis-
sion, it was not the only one, as six percent of non-
transmitting mothers had high viral loads of >100 000
copies/mL yet they did not transmit. Besides high levels
of viremia, other risk factors of vertical transmission
such as maternal host genetic factors, neutralizing anti-
bodies, HIV-1 phenotype and/or genetic diversity could
have also played a role in transmission.
Eighteen (28%) of the 64 mothers had undetectable
viral load yet some (n = 6) still transmitted the virus to
their infants. A Spanish study has also observed some
pregnant women with undetectable plasma viral load
who were at risk of vertically transmitting the HIV-1
RNA during vaginal delivery [22]. Quantification of
HIV-1 RNA in cervico-vaginal secretions has been
shown to be more useful when investigating vertical
transmission risk associated with vaginal delivery [23].
African mothers who are immigrants in Europe have
been shown to have lower HIV-1 RNA loads but were
more likely to vertically transmit relative to their non-
African counterparts [23-26] probably due to differences
in HIV-1 subtypes and host genetic factors. This group
of mothers with undetectable viral load could be elite
controllers [27-29]. Elite controllers have been shown to
maintain high levels of CD4
+ CD25
+ regulatory T cells
in their peripheral blood [30]. These are of high
research interest as they may provide novel insights
regarding host mechanism of virus control. The percen-
tage of the mothers with undetectable viral load in this
study was relatively higher compared to previous Zim-
babwean studies done in the late 1990 s which was
around 10% [8,31]. This could be attributed to differ-
ences in quantitation methods used. The fully auto-
mated COBAS AmpliPrep/COBAS TaqMan Viral RNA
load test used has been shown to excellently satisfy the
requirements for reliable quantification of HIV-1 RNA
in clinical specimens of all HIV-1 subtypes [32,33] and
the automation itself reduced inter and intra assay
variation.
Infant HIV-1 status was successfully determined using
qualitative Roche DNA PCR. This test has shown 100%
sensitivity and 100% specificity at least in Zimbabwean
infants and adults with predominant HIV-1 subtype C
[6,34]. The observed in utero and intra-partum/postpar-
tum transmission rates of 7.5%, and 15.3% were quite
comparable but lower relative to a previous Zimbab-
wean study that has shown in utero, intra-partum/early
postpartum and late postpartum transmission rates of
9.4%, 16% and 5.3%, respectively [6]. The rates were also
quite comparable to those obtained in a Tanzanian
cohort with an in utero and intra-partum transmission
rates of 8.4% and 16.1% respectively [19]. The overall
vertical transmission rate of 21.3% observed was much
l o w e rc o m p a r e dt ot h a to b t a i n e df r o mp r e v i o u ss t u d i e s
prior to antiretroviral prophylaxis era of 30.7% and 27%
[6,8]. This coincides with the general decrease in HIV-1
prevalence in the general population and could be
attributed to better access to antiretroviral prophylaxis.
However, in this cohort receiving single dose nevirapine
was not protective against HIV-1 vertical transmission
[35]. This could possibly be due to a relatively small
sample size. Intra-partum/postpartum transmissions
constituted the majority, 69% of the infections. Other
African studies have also shown such high transmission
rates through breastfeeding [36]. In resource poor set-
tings, where a large proportion of infants are infected
through breastfeeding, concerted efforts should be made
towards interventions aimed at reducing such transmis-
sions by advocating for more effective HAART during
pregnancy and or breastfeeding, encouraging exclusive
breastfeeding for six months, with ongoing breastfeeding
thereafter, during the introductions of complementary
feeds [37].
Generally male infants were more at risk of HIV-1
vertical transmission though this was not statistically
significant, unlike previous studies where in utero trans-
mission was significantly higher among girl than boy
infants [38]. Consistent with other studies was the fact
that, in utero infected infants were 2.5 times more likely
to die relative to intra-partum infected infants probably
because they would have been infected for longer peri-
ods [39].
As early as 1964, it was recognized that a decrease in
the TLC was associated with immune suppression [40].
The equipment and skills to perform total white blood
cell count and differentials are readily available in most
hospitals and clinics in resource-poor settings, and per-
forming a TLC costs much cheaper compared to CD4
cell count measurements. We applied WHO guidelines
t h a ta c k n o w l e d g et h a tT L Cm a yb eu s e da ss u r r o g a t e
marker for CD4 counts in situations where CD4 cell
count measurements may not be affordable. Observed
was a negative correlation between HIV-1 RNA load
and TLC. Pregnant women with high TLC were less
likely to transmit to their infants compared to those
with low counts and such findings have been observed
by others [16,18]. Anaemic mothers were more likely to
transmit to their babies. A mean decline of 0.46 g/dL
hemoglobin level per unit increase in log10 viral load
has been observed in a South African study [41]. This
value is relatively higher compared to 0.2 g/dL decrease
in hemoglobin levels observed in our study. This is
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only patients with acute HIV-1 infection which was not
the case with our study.
In this cohort being single, having multiple partners
and having a history of blood transfusion constituted
significant risk factors for HIV-1 sero-conversion follow-
ing delivery. Transmitting sero converters were more
likely to be young and have a travelling partner. Preven-
tion strategies should address these risk factors asso-
ciated with sero-conversion to reduce HIV-1 incidence
rates in the general population. In such poor resource
settings a nested case control design reduced costs and
efforts of data collection considerably with relatively
minor loss in statistical efficiency [42]. However, all
transmitting and non transmitting mothers selected in
the study may not be a full representation of all the
cases and controls in the original cohort due to failure
to follow up all the mothers and infants, though gener-
ally the follow-up rate was good.
Conclusion
We concluded that antenatal serum HIV-1 RNA viral
load, TLC and hemoglobin levels in the third trimester
were significantly associated with vertical transmission and
this association was independent of transmission time.
These data support the rationale for preventive strategies
designed to reduce vertical transmission through lowering
maternal viral load by introducing more effective HAART
during pregnancy, delivery and breastfeeding. Unclear are
the factors that contribute to the low viral load levels
which were observed in some transmitting mothers.
Further research is warranted to determine host genetic
factors among these mothers who had undetectable viral
load but still transmitted to their infants.
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